The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

In a recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98% specificity and 73% sensitivity across all stages.

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

All Babbo Italian Eatery profits on Feb. 26 benefit pancreatic cancer research. It's part of the annual Baseball for Babbo ...